Promising data presented from global phase III study with valoctocogene roxaparvovec in hemophilia A Jan. 12, 2021
Geron initiates phase III study of imetelstat in myelofibrosis refractory to JAK inhibitors Dec. 28, 2020
DISC-0974 decreases hepcidin and increases transferrin saturation in inflammation models Dec. 28, 2020
RSS